
A weight loss drug prescribed to adults to treat obesity has been found to be safe and effective in children as young as six, a study has found.
Liraglutide, which is sold under the brand name Saxenda, helped children between the ages of 6 and under 12 reduce their body mass index (BMI) by 7.4 per cent in a 56-week trial.